Nyloflam-SP + Tablet is a combination analgesic and anti-inflammatory medication containing Aceclofenac 100 mg, Paracetamol 325 mg, and Serratiopeptidase 15 mg. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), exerts potent anti-inflammatory, analgesic, and antipyretic effects by inhibiting cyclooxygenase enzymes, thereby reducing prostaglandin synthesis. Paracetamol complements this action by providing effective analgesia and antipyresis through central inhibition of prostaglandin synthesis without significant anti-inflammatory activity. Serratiopeptidase, a proteolytic enzyme, facilitates the breakdown of inflammatory mediators and promotes the resolution of inflammation and edema, enhancing tissue repair and reducing pain. Nyloflam-SP + Tablet is indicated for the management of acute and chronic musculoskeletal pain, osteoarthritis, rheumatoid arthritis, postoperative inflammation, and other inflammatory conditions where pain relief and reduction of swelling are required. The combination offers synergistic benefits, improving patient outcomes by targeting multiple pathways involved in pain and inflammation. It should be used under medical supervision, considering contraindications such as hypersensitivity to NSAIDs, active peptic ulcer disease, and severe hepatic or renal impairment. Common adverse effects may include gastrointestinal discomfort, nausea, and hypersensitivity reactions. Patient adherence to prescribed dosage and monitoring for side effects is essential for safe and effective therapy.